Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1358820 in Post-stroke Upper Limb Spasticity
NCT01205451Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by GSK. Started Sep 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01205451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205451.